NMAD NMAD

Q: What is the current share price of NMAD?

As of 2026-08-05 17:25 PDT, NMAD trades at $3.89 on NASDAQ/NYSE. Its 52-week range is $2.44 to $8.04.

Q: What is the market capitalisation of NMAD?

NMAD has a market capitalisation of $34.19M on NASDAQ/NYSE.

Q: What is the P/E ratio of NMAD?

NMAD trades at a trailing price-to-earnings (P/E) ratio of -3.09. Its price-to-book (P/B) ratio is 3.54.

Q: What is the return on equity (ROE) of NMAD?

NMAD has a return on equity (ROE) of -62.18%. Its return on capital employed (ROCE) is -44.80%.

Q: Is NMAD a good stock to buy?

This page provides a data-driven analysis of NMAD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Company Profile ↓

$3.89

-19.96% 1Y

Mkt Cap$34.19M

P/E-3.09

P/B3.54

52W High$8.04

52W Low$2.44

Book Value$1.10

EPS (TTM)$-1.26

Company Overview

NMAD (NMAD) is a publicly traded company listed on with a market capitalization of $34.19M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Conservative Balance Sheet

Carries low leverage with a debt-to-equity ratio of 0.07.

Growth & Price Performance

Stock Price Performance

1 Year:	-19.96%
6 Months:	+15.09%
3 Months:	-13.36%
1 Month:	-36.23%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish

52-Week Range 26% of range

$2.44 $8.04

Trend Signals

Price vs 50-DMABelow
Price vs 200-DMABelow
RSI (14)34.82 · Neutral

Price Performance

1M-36.23%

3M-13.36%

6M+15.09%

1Y-19.96%

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

In a confirmed uptrend (50-DMA above 200-DMA).

CONS

Trading 51.6% below its 52-week high.

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

-3.09

Industry PE

Forward P/E

PEG Ratio

Book Value

$1.10

Price to Book

3.54

P/S

EV/EBITDA

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

Profit 5Y

Revenue (YoY)

Earnings (YoY)

Profitability & Returns

ROCE

-44.80%

ROE

-62.18%

ROA

-47.19%

Profit Margin

Op Margin

Gross Margin

EPS (Latest Qtr)

$-0.18

EPS (TTM)

$-1.26

Balance Sheet & Liquidity

Debt/Equity

0.07

Quick Ratio

Current Ratio

3.88

Debt

$664.49K

Total Assets

$10.87M

Current Assets

$3.41M

Working Capital

$3.85M

Ownership

Promoter Holding

206.73%

Chg in Prom Hold

0.00%

FII / Inst Holding

5.00%

Chg in FII Hold

0.00%

Financial Snapshot

Enterprise Value

Total Revenue (TTM)

EBITDA

$-6.00M

Free Cash Flow

$-3.07M

Operating Cash Flow

$-3.07M

Shares Outstanding

8.79M

Gross Margin

Payout Ratio

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Sep 2013	Mar 2014	Jun 2014	Sep 2014	Mar 2015	Jun 2015	Sep 2015	Mar 2016	Jun 2016	Sep 2016	Mar 2017	Jun 2017	Sep 2017	Mar 2018	Jun 2018	Sep 2018	Mar 2019	Jun 2019	Sep 2019	Mar 2020	Jun 2020	Sep 2020	Mar 2021	Jun 2021	Sep 2021	Mar 2022	Jun 2022	Sep 2022	Mar 2023	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	706.94K	774.81K	1.80M	1.82M	1.99M
Operating Income	-313.05K	-715.78K	-517.28K	-501.42K	-752.16K	-500.69K	-779.71K	-416.55K	-555.02K	-647.08K	-602.60K	-292.94K	-463.22K	-379.76K	-371.94K	-1.03M	-438.74K	-627.89K	-1.09M	-387.16K	-373.39K	-1.60M	-1.73M	-1.73M	-1.24M	-1.65M	-1.55M	-1.48M	-1.37M	-1.67M	-1.02M	-966.88K	-1.01M	-983.26K	-	-706.94K	-774.81K	-1.80M	-1.82M	-1.99M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-706.42K	-773.86K	-1.98M	-2.54M	-1.98M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.13K	1.81K	457	3.76K	3.10K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-709.55K	-775.67K	-1.98M	-2.54M	-1.99M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-313.05K	-928.82K	-741.33K	-501.39K	-957.92K	-500.65K	-779.69K	-416.54K	-555.00K	-646.94K	-620.59K	-292.78K	-462.42K	-379.16K	-371.42K	-1.03M	-428.74K	-610.46K	-1.08M	-383.18K	-373.12K	-1.60M	-1.73M	-1.73M	-1.24M	-1.66M	-1.55M	-1.48M	-1.37M	-1.67M	-1.02M	-971.32K	-1.01M	-986.03K	-	-709.55K	-775.67K	-1.98M	-2.54M	-1.92M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.95	-0.89	-0.82	-1.00	-0.49	-0.43	-0.45	-0.44	-	-0.29	-0.29	-0.33	-	-0.18
R&D Expense	219.90K	162.77K	335.72K	309.10K	505.51K	287.02K	624.40K	264.50K	316.95K	335.95K	143.24K	14.56K	205.67K	25.69K	41.11K	3.45K	48.31K	80.12K	570.60K	94.67K	117.95K	799.42K	443.53K	262.42K	227.18K	458.45K	164.81K	272.39K	189.09K	427.46K	132.49K	119.06K	210.71K	361.63K	-	91.46K	60.65K	50.70K	-	333.38K

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	0	0	0	0	-	200.00K	-	-	-	-	-	-	0	0	0	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6.31M	5.09M	3.57M	5.11M
Operating Income	-	-	-	-	-881.68K	-1.87M	-2.11M	-1.37M	-2.40M	-2.65M	-2.13M	-1.81M	-2.14M	-2.49M	-3.27M	-	-6.31M	-5.09M	-3.57M	-5.11M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6.30M	-5.07M	-3.57M	-6.00M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.88K	16.23K	16.82K	9.16K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6.31M	-5.09M	-3.59M	-6.01M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-562.08K	-1.65M	-1.27M	-1.55M	-880.25K	-2.07M	-3.58M	-1.37M	-2.77M	-2.85M	-2.13M	-1.81M	-2.13M	-2.44M	-3.26M	-	-6.31M	-5.09M	-3.59M	-6.01M
Diluted EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3.99	-2.66	-1.59	-1.26
R&D Expense	-	-	-	-	445.54K	1.33M	1.01M	879.89K	1.12M	2.09M	870.01K	467.26K	40.70K	820.91K	1.22M	1.74M	1.35M	898.10K	726.23K	254.92K

Balance Sheet (Annual)

Figures in USD.

Metric	Aug 2005	Dec 2005	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	-	-	-	-	1.93M	429.77K	1.75M	558.04K	539.30K	597.98K	433.41K	1.37M	4.34M	2.67M	5.23M	-	5.56M	4.31M	1.15M	12.73M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.56M	4.31M	1.15M	5.18M
Cash & Equivalents	-	-	-	-	-	-	-	-	1.66M	475.02K	44.41K	25.28K	199.93K	1.31M	4.27M	2.60M	5.07M	-	5.35M	4.20M	1.04M	5.11M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	273.44K	-	218.65K	-	-	-	-	-	395.76K	313.86K	318.28K	1.77M
Current Liabilities	-	-	-	-	-	-	195.06K	350.75K	261.15K	321.77K	273.44K	285.64K	218.65K	373.02K	210.91K	237.90K	216.52K	-	395.76K	313.86K	318.28K	1.33M
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	664.49K
Total Equity	0	-14.62K	552.56K	376.93K	-323.55K	1.30M	1.74M	79.02K	1.49M	236.27K	265.86K	312.33K	214.76K	995.04K	4.13M	2.43M	5.01M	-	5.17M	3.99M	827.22K	9.66M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.66M	2.25M	2.25M	8.79M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	-936.39K	-1.36M	-1.21M	-1.18M	-1.64M	-2.18M	-1.68M	-1.41M	-1.51M	1.67M	-2.13M	-	-4.61M	-4.29M	-3.16M	-3.07M
Investing Cash Flow	-1.58M	1.25M	345.00K	-1	-207.56K	109.60K	104.09K	-	-	-	-	-	-	-	0	-3.17M
Financing Cash Flow	1.09M	5.00K	2.50M	0	1.41M	2.05M	1.75M	2.52M	4.48M	-	4.60M	-	5.14M	3.14M	0	10.31M
Capital Expenditure	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-	-	-	-	-	-	-4.61M	-4.29M	-3.16M	-3.07M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	529.65K	-1.15M	-3.16M	4.07M
Share Buybacks	-	-	-	-	-	-	-	-	24.70K	-	-	-	-	-	-	-

Ratios (Annual)

Figures in %.

Metric	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin %	-	-	-	-	-	-	-	-	-	-1,323.2%	-	-	-	-	-	-	-	-	-	-
Net Margin %	-	-	-	-	-	-	-	-	-	-1,426.1%	-	-	-	-	-	-	-	-	-	-
ROE %	-101.7%	-437.4%	393.0%	-119.2%	-50.7%	-2,617.0%	-239.9%	-581.9%	-1,040.5%	-913.2%	-994.0%	-181.7%	-51.7%	-100.3%	-65.1%	-	-122.2%	-127.3%	-433.5%	-62.2%
ROCE %	-	-	-	-	-50.8%	-2,364.2%	-141.2%	-581.9%	-903.9%	-847.3%	-994.1%	-181.9%	-51.8%	-102.3%	-65.2%	-	-122.2%	-127.4%	-431.9%	-44.8%

Shareholding Pattern

Insiders

206.73%

Institutions

5.00%

Public Float

-4.69%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for NMAD

Google News ue, 07 Jul 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE41UksyTmJFaWNIdU5lXzJkemNvdENKQ0taLXVqd3p0VGlINDlZam16QlZUNmtJcU12ZUdjbUpoTUtxRk5WZVVoY0t5SmdBV3J2?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>  <fon…

Google News Mon, 03 Aug 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOMnd4M3ZxdkFMZUo2SjJ4OFR3R3ZybDNEcG0tRS00YWNVQkROaXVMLTBLQUR2Tmh3SnYyd01QcnZqS1pqVXZsUUxzaWxZVjFiME9YZHJtUGhKdUZvcGpzbXhrRDBLc1I3dWdyWXh0UXFIYW8wVE9tWjktOUR0b3ZleXdvMWwyNlhNOHpwT0…

Google News Fri, 31 Jul 2026

NOMAD Power Solutions stock now tradable in options on Cboe under NMAD - TradingView

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNSnJtSUw1RWUyeXpwVDdiQ25LeXYtWU5tTXJXZjRGekdTQng1ajNsOGE2QTJ6YlZ5dzlkdV9VU25Dc0F5YnpNbEl0Y3BQLTIwdEV1TjJsaVNXVlpCNE1xWkt4RUxjaHR0Y0RkTnVZcVVtWlpZaHJlUWNObl9paHdYYTJlY2dKTDJ2bGZVVl…

Google News Fri, 31 Jul 2026

NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange - GlobeNewswire

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxQb0hyNGQ1RG8teVA1bFdPVkhRdVRidDd4TWloak5RRGJxa1VEMlRla0tvVnFDSUJCZjRoTjJveE45SE9Pakh4YTJsVkpOVEdKNmxjRVF1ME90ZWVxOFVqSEphb3RLbFE0WC1wUGZVUGk2emlaQmFBRjhsQ0xzajVHZTNtQV9Hdy1NZjFmRX…

Google News Fri, 31 Jul 2026

Nomad Power Solutions (LIXT) adds Cboe options trading - Stock Titan

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPVXNxajUwQy1SR0todHBpUG9reXVZWTVfNHA4TWJOUGhBaWhpeG43Qk9Yc25QbUlSRzBON1pnU244X0tzWHkwOTctRHlRdTFaR0hSbVJTRElRUDdyM0pjcVA3eFhPQTZERVlOMUVQX0M0N1hGMjFSTjFPM24wRUg3QXM0bDBzdW82dEJOYn…

Google News Mon, 13 Jul 2026

Is Nomad Foods Limited (NOMD) Stock Undervalued Right Now? - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNUERIX2N5Um1wWFQ5VjZmWV9CQXhoWndUX251ZUpzeEdJT3ZkRzlka3NfaUFFVlVTYWJRdW9TczlNeWRUTTN2bTc3N3BkLXFUZ0JielJMS1ZTUjd3M0paV0xUd3ItaVo1cU10bEZvZUt0bjE5WXVPU1dKcUROOEJoa0FtV01ueW1GU2RmSk…

NMAD — Frequently Asked Questions

What is the current share price of NMAD?

As of 2026-08-05 17:25 PDT, NMAD trades at $3.89 on NASDAQ/NYSE. Its 52-week range is $2.44 to $8.04.

What is the market capitalisation of NMAD?

NMAD has a market capitalisation of $34.19M on NASDAQ/NYSE.

What is the P/E ratio of NMAD?

NMAD trades at a trailing price-to-earnings (P/E) ratio of -3.09. Its price-to-book (P/B) ratio is 3.54.

What is the return on equity (ROE) of NMAD?

NMAD has a return on equity (ROE) of -62.18%. Its return on capital employed (ROCE) is -44.80%.

Is NMAD a good stock to buy?

This page provides a data-driven analysis of NMAD, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

NMAD NMAD

Company Overview

Why Investors Should Care

Growth & Price Performance

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Analyst View

Latest News

symbol__ Stock Quote Price and Forecast - CNN

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

NOMAD Power Solutions stock now tradable in options on Cboe under NMAD - TradingView

NOMAD Power Solutions Announces Options Trading Begins on Cboe Options Exchange - GlobeNewswire

Nomad Power Solutions (LIXT) adds Cboe options trading - Stock Titan

Is Nomad Foods Limited (NOMD) Stock Undervalued Right Now? - Yahoo Finance

NMAD — Frequently Asked Questions

What is the current share price of NMAD?

What is the market capitalisation of NMAD?

What is the P/E ratio of NMAD?

What is the return on equity (ROE) of NMAD?

Is NMAD a good stock to buy?

Explore More